ليست عنوان مقالات لاتين m-Xylylenediaminium sulfate: crystal structure and Hirshfeld surface analysis Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

m-Xylylenediaminium sulfate: crystal structure and Hirshfeld surface analysis

2

My 25 years of teaching at KFUPM (King Fahd University of Petroleum & Minerals) and the equation of driving force

3

MY AFRO-LATIN AMERICA: INTRODUCTION TO COSMOLOGICAL HISTORY

4

My avatar, my self: Virtual harm and attachment

5

My best choice after a round trip from illness

6

My Blue Heaven: Life and Politics in the Working-Class Suburbs of Los Angeles, 1920–1965.: Becky M. Nicolaides; University of Chicago Press, Chicago, 2002

7

My carrel, my second home: Inclusion and the sense of belonging among visually impaired students in an academic library

8

My chaotic career—from billiard balls to economic dynamics and financial markets

9

My Conception of Philosophy

10

My Country My Life

11

My country, right or wrong: Does activating system justification motivation eliminate the liberal-conservative gap in patriotism?

12

My crazy negative world

13

My Dear Colleagues

14

My Dear Departed Aunt

15

My debt to Walter Kauzmann Original Research Article

16

My dentist hands me a mirror

17

My dragonfly flies upside down! Using Second Life in multimedia design to teach students programming

18

My dream quadrature rule

19

My enemyʹs enemy is my friend”: Using phages to fight bacteria

20

My experiences with Parkinsonʹs disease

21

My face or yours? Event-related potential correlates of self-face processing

22

My face through the looking-glass: The effect of mirror reversal on reflection size estimation

23

My face, a window to communication: Using creative design in learning

24

My Favorite Experiment Series. A POP BOTTLE AS A HELMHOLZ RESONATOR

25

My Favorite Experiment Series. PART 2: FREE FALL ONTO A SPRING

26

My Favorite Experiment Series. PART 3: MEASURING PERFORMANCE OF A TOY CAR UNDER FORCE OF GRAVITY

27

My fifty-year odyssey in obstetrics and gynecology, : Presidential address

28

My first 40 years as editor: A note to PMS readers

29

My Flower Has Only Four Thorns

30

My Fond Farewell

31

My friend and mentor Tom—reminiscing a twenty five year long friendship

32

My friend and mentor Tom—reminiscing a twenty five year long friendship

33

My future self: Young childrenʹs ability to anticipate and explain future states

34

My Home Was My Castle: Evictions and Repossessions in Britain,

35

My hope for medicine

36

My Husband Always Crosses the Line’: Textual Identity and Presentation of ‘the Self’ in Family Conflict Communication

37

My interest in the department of medical education

38

My Journey with and in Kidney Diseases

39

My librarian: Personalized research clinics and the academic library

40

My Life as an Editor - Maeve O Connor

41

My life in feedback and feedback in my life

42

My life with John A. Schellman Original Research Article

43

My life with progesterone

44

My life with the fetal-placental unit

45

My lost museum: User expectations and motivations for creating personal digital collections on museum websites Original Research Article

46

My Love Affair With an Instrument

47

My Observations and Opinions on LIS Profession and its Education in Pakistan

48

My Odyssey with Sir John Eccles

49

50

My older sibling was drunk – Younger siblingsʹ drunkenness in relation to parental monitoring and the parent–adolescent relationship

51

My oldest patient

52

53

54

My part in Marxʹs downfall: Hobsbawm, history and the politics of personality: E. Hobsbawm, Interesting Times: A Twentieth Century Life, Allen Lane, London, 2002.

55

My patient has a lot of variability in his blood pressure measurements? Should I be worried? What can I do which may be better?

56

My Patient has an elevated hs-CRP. What does this mean? What should I do now?

57

My patient has carotid stenosis. Should he get stenting or endarterectomy?

58

My patient has had an intracerebral haemorrhage — How do I best control his blood pressure?

59

My patient has intracranial stenosis, does he need an intracerebral stent? Results of the SAMMPRIS study

60

My Patients Have THAT in Their Mouths? Identifying Patients at Risk for Pneumonia

61

My peers, my friend, and I: Peer interactions and somatic complaints in boys and girls

62

My People, My Country: A New Interpretation of Chinese Main Melody Film in the New Era

63

My Personal Philosophy for Academic Medicine

64

My personal search engine

65

My Personal Teaching Principle is ‘Safe, Fun, and Clear’ : Reflections of a TESOL Teacher

66

My Professional Life in Higher Education: The Journey of Teaching and Leading

67

My relations to the late Prof. Shigeo Shionoya

68

My role is my castle — The appeal of family roles after experiencing social exclusion

69

My saga with earthworms

70

My Salieri Complex: An Untold Story of Griffin and Kemp

71

My scale or your meter? Evaluating methods of measuring the Internet

72

My Scientific Odyssey: Uner Tan

73

My selves and I: identity markers in work meeting talk

74

75

My surgeon father who was not a Catholic

76

My twenty-five years of cloze testing research: So what?

77

My unusually dedicated mentor Original Research Article

78

My View and My Experience on Extracardiac RV-PA Conduit

79

My voyage of discovery to proteins in flatland …and beyond

80

My way: How strategic preferences vary by negotiator role and regulatory focus

81

My winter world: the illness of Gerard Manley Hopkins

82

Myalgic encephalomyelitis in children

83

Myanmar Language Sketch Soft Keyboard on Android

84

Myanmar’s Rohingya Refugees in Malaysia: Education and the Way Forward

85

Myard linkage and its mobile assemblies

86

Myard’s first five-bar linkage as a degeneracy of a plane-symmetric six-bar loop

87

Myasthenia gravis

88

Myasthenia gravis : Presentation and outcome in 104 patients managed in a single institution

89

Myasthenia gravis and coronavirus disease 2019: A report from Iran

90

Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis

91

Myasthenia gravis and levonorgestrel implant

92

Myasthenia Gravis and Related Disorders: H.J. Kaminski, The Human Press, 2002, ISBN 1-58829-058-1, price US$ 125.00 (hardback), 408 pages

93

Myasthenia gravis and scleroderma: Two cases and a review of the literature

94

MYASTHENIA GRAVIS AND SEVOFLURANE - A Case Report -

95

Myasthenia gravis as a presenting feature in a patient with lung cancer: A case report

96

MYASTHENIA GRAVIS ASSOCIATED WITH AUTOIMMUNE THYROID DISEASE: A REPORT OF TWO PATIENTS

97

Myasthenia gravis from Thomas Willis to the present

98

MYASTHENIA GRAVIS IN IRANIAN CHILDREN

99

Myasthenia gravis in Iranian children

100

Myasthenia gravis on the Dutch antilles: an epidemiological study

101

Myasthenia gravis presenting as a unilateral abducens nerve palsy

102

Myasthenia gravis with acute respiratory failure in the emergency department

103

Myasthenia gravis with autoimmune autonomic neuropathy

104

Myasthenia Gravis: A Comparisonof Clinical Presentation and Diagnostic Tests among different Gender Groups in Pakistani Population

105

Myasthenia gravis: an illustrated history: By John Keesey, MD, 2002, Roseville, California, Publishers Design Group, 120 pp, illustrated, $49.95, ISBN: 1-929170-04-1

106

Myasthenia gravis: recommendations for clinical research standards

107

Myasthenia gravis-associated systemic vasculitis and myocarditis with involvement of the cardiac conducting tissue

108

Myasthenic crisis after botulinum toxin

109

Myasthenic crisis presenting as isolated vocal cord paralysis

110

Myatt, G.J. (2007). Making sense of data: a practical guide to exploratory data analysis and data mining (pp. 280). Wiley.

111

MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo

112

Myb protein specificity: evidence of a context-specific transcription factor code

113

MYB transcription factors in Arabidopsis

114

MYB transcription factors in Arabidopsis

115

MYB98 Is Required for Pollen Tube Guidance and Synergid Cell Differentiation in Arabidopsis

116

MYBBP1a is a Novel Repressor of NF-κB

117

MyBP-C phosphorylation in donor, failing and HOCM human heart muscle

118

Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor

119

MYC amplification and TERT expression in breast tumor progression

120

MYC Amplification in Two Further Cases of Acute Myeloid Leukemia with Trisomy 4 and Double Minute Chromosomes

121

MYC gene amplification in double minute chromosomes in an aggressive large B-cell lymphoma with leukemic presentation: a case report

122

MYC genes with differential responses to tapping, mechanical wounding, ethrel and methyl jasmonate in laticifers of rubber tree (Hevea brasiliensis Muell. Arg.)

123

MYC in gastric carcinoma and intestinal metaplasia of young adults

124

MYC on the Path to Cancer

125

MYC Participates in Lipopolysaccharide-Induced Sepsis via Promoting Cell Proliferation and Inhibiting Apoptosis

126

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

127

Myc: A Weapon of Mass Destruction

128

Mycaloside A, a new steroid oligoglycoside with an unprecedented structure from the Caribbean sponge Mycale laxissima

129

Mycangial fungus benefits the development of a leaf-rolling weevil, Euops chinesis

130

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

131

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

132

Mycelia of Mucor rouxii as a source of chitin and chitosan

133

Mycelial Compatibility Grouping and Aggressiveness of Sclerotinia sclerotiorum on Different Hosts in North of Iran

134

Mycelial Compatibility Groupings and Pathogenic Diversity of Sclerotinia sclerotiorum (Lib.) de Bary Populations on Canola in Golestan Province of Iran

135

Mycelial compatibility groups in Sclerotium cepivorum

136

Mycelial compatibility reactions of Australian Fusarium graminearum and F. pseudograminearum isolates compared with AFLP groupings

137

Mycelial growth and exclusion of Heterobasidion parviporum inoculated in branches of 15-year-old Picea abies clones

138

Mycelial growth of Philippine mushroom Lentinus tigrinus in selected cucurbit-based media and its antioxidant activity

139

Mycelium differentiation and development of Streptomyces coelicolor in lab-scale bioreactors: Programmed cell death, differentiation, and lysis are closely linked to undecylprodigiosin and actinorhodin production

140

Mycelium growth and degradation of creosote-treated wood by basydiomycetes

141

Mycelium of arbuscular mycorrhizal fungi increases soil water repellency and is sufficient to maintain water-stable soil aggregates

142

Mycelium of arbuscular mycorrhizal fungi increases soil water repellency and is sufficient to maintain water-stable soil aggregates

143

Mycelium-bound carboxylesterase from Aspergillus oryzae: an efficient catalyst for acetylation in organic solvent

144

Mycenae and Tiryns: the Pottery of the Second Half of the Thirteenth Century BC - Contexts and Definitions

145

Mycenae Revisited Part 2. Exploring the Local versus Non-local Geographical Origin of the Individuals from Grave Circle A: Evidence from Strontium

146

Mycenae Revisited Part 3. The Human Remains from Grave Circle A at Mycenae. Behind the Masks: A Study of the Bones of Shaft Graves I–V

147

Mycetoglyphus qassimi and Tyrophagus putrescentiae, Two Acarid Mites Recovered from Palm Fields, Feeding on Root-Knot Nematode Meloidogyne javanica in Al-Qassim Area, Saudi Arabia

148

149

Mycetoma Caused by Acremonium Species ina Patient with Chronic Granulomatous Disease

150

Mycetoma revisited :Incidence of various radiographic signs

151

MYCETOMA: A LOCAL EXPERIENCE

152

Mycetoma: A report of 8 cases at tertiary care hospital in Central India with review of literature

153

Mycetozoal bloom in a hydroponic culture of garden cress (Lepidium sativum L.)

154

Mycielski approach for wind speed prediction

155

Myc—Is this the oncogene from Hell?

156

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

157

MYCN Gene Copy Number Status Detected by FISH Method and Its Correlation with Outcome and Clinicopathological Variables in Childhood Neuroblastoma

158

MYCN in neuronal tumours

159

MYCN oncoprotein targets and their therapeutic potential

160

Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation

161

MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells

162

Myco-agro sorbents: novel heavy metal sequesters

163

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

164

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

165

Mycobacteria and sarcoidosis

166

Mycobacteria in the environment of pig farms in the Czech Republic between 2003 and 2007

167

Mycobacteria in water, feedstocks and food: analysis of publications

168

Mycobacteria, but not mercury, induces metallothionein (MT) protein in striped bass, Morone saxitilis, phagocytes, while both stimuli induce MT in channel catfish, Ictalurus punctatus, phagocytes

169

Mycobacteria: Genetics of Resistance and Implications for Treatment

170

Mycobacterial ABC Transport System: Structure of the Primary Phosphate Receptor

171

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

172

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

173

Mycobacterial disease in renal allograft recipients

174

Mycobacterial disease: A historical and epidemiologic perspective

175

Mycobacterial DNA Gyrase: Enzyme Purification and Characterization of Supercoiling Activity

176

Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis

177

Mycobacterial formulation in liposomes showed decreased expression of CD95/CD95L and caspase activity in T cells of leprosy patients

178

Mycobacterial Gene Cloning and Expression, Comparative Genomics, Bioinformatics and Proteomics in Relation to the Development of New Vaccines and Diagnostic Reagents

179

Mycobacterial granulomas: keys to a long-lasting host–pathogen relationship

180

Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma

181

Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study

182

Mycobacterial infections in multiple species: Implications for diagnosis and control

183

Mycobacterial Phenolic Glycolipid Virulence Factor Biosynthesis: Mechanism and Small-Molecule Inhibition of Polyketide Chain Initiation Original Research Article

184

Mycobacterial protein boosts BCG immunity

185

Mycobacteriosis in fishes: A review

186

MYCOBACTERIUM ULCERANS INFECTION (BURULI ULCER): FIRST REPORTED CASE IN A TRAVELER

187

Mycobacterium abscessus in a long-term respiratory care unit

188

Mycobacterium arupense among the isolates of non-tuberculous mycobacteria from human, animal and environmental samples

189

Mycobacterium Avium and Mycobacterium intracellulare Infections in Slaughtered Pigs in Makurdi, North-Central Nigeria: An Emerging Zoonosis

190

Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10

191

Mycobacterium avium subsp. avium in domestic pigeons (Columba livia f. domestica) diagnosed by direct conventional multiplex PCR: a case report

192

Mycobacterium avium subsp. Paratuberculosis in a mouflon herd without clinical symptoms monitored using IS900 real-time PCR: a case report

193

Mycobacterium avium subsp. paratuberculosis in muscle, lymphatic and organ tissues from cows with advanced Johneʹs disease

194

Mycobacterium avium subsp. paratuberculosis induces differential cytosine methylation at miR-21 transcription start site region

195

Mycobacterium avium subsp. paratuberculosis survival during fermentation of soured milk products detected by culture and quantitative real time PCR methods

196

Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease

197

Mycobacterium Avium Subspecies Paratuberculosis Multibacillary Infection (Johne’s disease) ina Teddy Goat

198

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

199

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

200

Mycobacterium avium subspecies paratuberculosis: A possible causative agent in human morbidity and risk to public health safety

201

Mycobacterium avium subspecies paratuberculosis: the nature of the problem

202

Mycobacterium avium subspecies paratuberculosisA Review of Present Research in Norway

203

Mycobacterium aviumComplex Activates Nuclear Factor κB via Induction of Inflammatory Cytokines

204

Mycobacterium aviumReduces Expression of Costimulatory/Adhesion Molecules by Human Monocytes

205

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

206

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

207

Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human β-defensin-2 gene transcription in human epithelial cells

208

Mycobacterium bovis Bacillus Calmette–Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells

209

Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells

210

Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced CXCL8 production is mediated through PKCα-dependent activation of the IKKαβ signaling pathway in epithelial cells

211

Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection

212

Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells

213

Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response

214

Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae

215

Mycobacterium bovis in Korea: An update

216

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

217

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

218

Mycobacterium bovis infection in domestic pigs in Great Britain

219

Mycobacterium bovis infection: Everything but the cow

220

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain 2004–2010

221

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 2: A review of diagnostic methods

222

Mycobacterium bovis tuberculins: Preparation and antigenic properties

223

Mycobacterium bovis tuberculosis: forgotten, but not gone

224

Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of bacille Calmette-Guérin

225

Mycobacterium bovis: guidance on BCG vaccination is needed

226

Mycobacterium boviss Infection and Tuberculosis in Cattle

227

Mycobacterium chelonae interface infection after endokeratoplaty

228

Mycobacterium chelonae keratiti after laer in itu keratomileui uccefully treated with medical therapy and flap removal

229

Mycobacterium chelonae Keratitis Following Laser in situ Keratomileusis (LASIK) Specifically Identified by INNO-LIPA Method

230

Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms

231

Mycobacterium fortuitum-induced surgical wound infection - a case report

232

Mycobacterium gordonae in fiberoptic bronchoscopes

233

Mycobacterium leprae-induced demyelination: a model for early nerve degeneration

234

Mycobacterium marinum

235

Mycobacterium marinum as a cause of skin chronic granulomatous in the hand

236

Mycobacterium marinum hand infection: case reports and review of literature

237

Mycobacterium Marinum Infection after Infliximab Therapy

238

Mycobacterium marinum infection: A case report

239

Mycobacterium mucogenicum and Klebsiella pneumoniae Pulmonary Infection in a Patient Following Cardiac Surgery: A Case Report

240

Mycobacterium mucogenicum causing central line-related sepsis in a home parenteral nutrition patient

241

Mycobacterium mucogenicum meningitis due to external ventricular drain

242

Mycobacterium paratuberculosis and Milk

243

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

244

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

245

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

246

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

247

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

248

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

249

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

250

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

251

Mycobacterium simiae Isolates Subtypes and Molecular Drug Susceptibility in Iran

252

Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan

253

Mycobacterium Thermoresistibile Infection in a Child

254

Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitro

255

Mycobacterium tuberculosis and bovis as causes for shrinking bladder

256

Mycobacterium tuberculosis and Cryptococcus neoformans co-infection meningitis in a young immuncompetent woman

257

Mycobacterium tuberculosis and Dual M. tuberculosis/M. bovis Infection as the Cause of Tuberculosis in a Gorilla and a Lioness, Respectively, in Ibadan Zoo, Nigeria

258

Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence

259

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

260

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

261

Mycobacterium tuberculosis and pemphigus vulgaris

262

Mycobacterium Tuberculosis Breast Infection Mimicking Pyogenic Abscesses in Kuwait

263

Mycobacterium tuberculosis Detection based on mpt64 amplification by Nested-PCR in Sputum samples

264

Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso

265

Mycobacterium tuberculosis genome sequence illuminates bugʹs biology

266

Mycobacterium tuberculosis GroEL Homologues Unusually Exist as Lower Oligomers and Retain the Ability to Suppress Aggregation of Substrate Proteins

267

Mycobacterium tuberculosis H37Rv3377c encodes the diterpene cyclase for producing the halimane skeleton

268

Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis

269

Mycobacterium tuberculosis Hsp16.3 Nonamers are Assembled and Re-assembled via Trimer and Hexamer Intermediates

270

Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli

271

Mycobacterium tuberculosis infection and FHIT gene alterations in lung cancer

272

Mycobacterium tuberculosis infection in grazing cattle in central Ethiopia

273

Mycobacterium tuberculosis infection in travellers: tuberculosis comes home

274

Mycobacterium tuberculosis infection in women with unexplained infertility

275

Mycobacterium tuberculosis infection presenting with cutaneous abscess and osteomyelitis

276

Mycobacterium Tuberculosis Infection: Participation of TH1, TH2, TH17 and Regulatory T Cells in the Immune Response

277

Mycobacterium tuberculosis Inhibits MHC Class II Antigen Processing in Murine Bone Marrow Macrophages

278

Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation

279

Mycobacterium tuberculosis Protein Tyrosine Phosphatase PtpB Structure Reveals a Diverged Fold and a Buried Active Site

280

Mycobacterium tuberculosis Ribose-5-phosphate Isomerase has a Known Fold, but a Novel Active Site

281

Mycobacterium tuberculosis spoligotypes circulating in the Lebanese population: a retrospective study

282

Mycobacterium tuberculosis Thymidylate Kinase: Structural Studies of Intermediates along the Reaction Pathway

283

Mycobacterium tuberculosis transmission and HIV status

284

Mycobacterium tuberculosis transmission and HIV status

285

Mycobacterium tuberculosis transmission and HIV status

286

Mycobacterium tuberculosis β-ketoacyl-ACP reductase: α-Secondary kinetic isotope effects and kinetic and equilibrium mechanisms of substrate binding

287

Mycobacterium tuberculosis: a stowaway in the cell

288

Mycobacterium tuberculosisComplex DNA in Ancient Human Bones

289

Mycobacterium ulcerans

290

Mycobacterium ulcerans disease (Buruli ulcer) following human bite

291

Mycobacterium ulcerans infection Review Article

292

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial

293

Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak

294

Mycobial enhancement of ergothioneine by submerged cultivation of edible mushroom mycelia and its application as an antioxidative compound

295

Mycobiota and aflatoxin B1 contamination of Piper guineense (Ashanti pepper), P. nigrum L. (black pepper) and Monodora myristica (calabash nutmeg) from Lagos, Nigeria

296

Mycobiota and aflatoxin B1 contamination of rainbow trout(Oncorhinchus mykiss) feed with emphasis toAspergillus section Flavi

297

Mycobiota and co-occurrence of mycotoxins in Capsicum powder

298

Mycobiota and identification of aflatoxin gene cluster in marketed spices in West Africa

299

Mycobiota and mycotoxin contamination of maize flours and popcorn kernels for human consumption commercialized in Spain Original Research Article

300

Mycobiota and mycotoxin producing fungi from cocoa beans

301

Mycobiota and mycotoxins in Brazil nut samples from different states of the Brazilian Amazon region

302

Mycobiota and mycotoxins in Brazilian peanut kernels from sowing to harvest

303

Mycobiota and mycotoxins present in finished fish feeds from farms in the Rio de Janeiro State, Brazil

304

Mycobiota and natural occurrence of aflatoxin, deoxynivalenol, nivalenol and zearalenone in rice freshly harvested in South Korea

305

Mycobiota and Toxigenecity Profile of Aspergillus flavus Recovered from Food and Poultry Feed Mixtures in Cameroon

306

Mycobiota associated with larval mines of Thrypticus truncatus and T. sagittatus (Diptera, Dolichopodidae) on waterhyacinth, Eichhornia crassipes, in Argentina

307

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

308

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

309

Mycobiota in the processing areas of two different meat products

310

Mycobiota of cocoa: From farm to chocolate Original Research Article

311

Mycobiota of the arid Middle East: check-list of novel fungal taxa introduced from 1940 to 2000 and major recent biodiversity titles

312

Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome

313

Mycoediketopiperazine, a novel fungal metabolite from a Papularia sp.

314

Mycoflora and absence of aflatoxin contamination of commercialized cassava chips in Benin, West Africa

315

Mycoflora and mycotoxins in field samples of Brazil nuts

316

Mycoflora and natural occurrence of aflatoxins and fumonisin B1 in cassava and yam chips from Benin, West Africa

317

Mycoflora and nutritional components of cocoa powder samples in South West Nigeria

318

Mycoflora and occurrence of aflatoxin in dried vegetables in Benin, Mali and Togo, West Africa

319

Mycoflora and ochratoxin A producing strains of Aspergillus in Algerian wheat

320

Mycoflora and Water Quality index Assessment of Water Sources in Oproama, Niger Delta, Nigeria

321

Mycoflora associated with cucurbits

322

Mycoflora Associated with Some Textiles in Jeddah City

323

Mycoflora associated with stored seeds of soybean

324

Mycoflora associated with tomato during the process of marketing

325

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

326

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

327

Mycoflora of human external auditory canal in Shiraz, southern Iran

328

Mycoflora of Ostrich (Struthio camelus) gastrointestinal tract as a human hazard

329

Mycoflora of paddy and milled rice produced in the region of Northeastern Argentina and Southern Paraguay

330

Mycoflora of pistachio and peanut kernels from Sari, Iran

331

Mycoflora of pistachio and peanut kernels from Sari, Iran

332

Mycoflora of the Interdigital Spaces Among Girl Students in Ahvaz, Iran

333

Mycogenesis of cerium oxide nanoparticles using Aspergillus niger culture filtrate and their applications for antibacterial and larvicidal activities

334

Mycogenesis of silver nanoparticles by different Aspergillus species

335

Mycogenic nanoparticles and their bio‑prospective applications: current status and future challenges

336

Myco-heterotroph/epiparasitic plant interactions with ectomycorrhizal and arbuscular mycorrhizal fungi

337

Mycohydrometallurgy: Biotransformation of double refractory gold ores by the fungus, Phanerochaete chrysosporium

338

Myco-hydrometallurgy: Coal model for potential reduction of preg-robbing capacity of carbonaceous gold ores using the fungus, Phanerochaete chrysosporium

339

Mycoinsecticides and Mycoacaricides: A comprehensive list with worldwide coverage and international classification of formulation types

340

Mycolactones and Mycobacterium ulcerans disease

341

Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis Original Research Article

342

Mycolic Acids Constitute a Scaffold for Mycobacterial Lipid Antigens Stimulating CD1-Restricted T Cells Original Research Article

343

Mycological and histopathological findings of experimental disseminated candidiasis in dogs

344

Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts

345

Mycological assessment of sediments in Ligurian beaches in the Northwestern Mediterranean: Pathogens and opportunistic pathogens

346

Mycological Evaluation of Imported Frozen Fish

347

Mycological evaluation of the phylloplane of Vigna unguiculata (L.) Walp

348

Mycological Identification of Some Fungi Isolated from Meat Products and Spices with Molecular Identification of Some Penicillium Isolates

349

Mycological investigation in patients with acute otitis media

350

Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples

351

Mycological quality and mycotoxin contamination of Sri Lankan peppers (Piper nigrum L.) and subsequent exposure assessment

352

Mycological Study of Superficial-cutaneous Mycoses in Tehran, Iran

353

Mycological Survey and Total Aflatoxin Analyze in Silage from Qaemshahr City (Northern Iran)

354

Mycological survey of ripped service tree fruits (Sorbus domestica L.) with an emphasis on toxinogenic fungi

355

Mycoparasitism of Ampelomyces quisqualis Ces. ex Schlecht on Powdery Mildew Fungi in Syria

356

Mycoparasitism of Pythium ultimum by Antagonistic Binucleate Rhizoctonia Isolates in Agar Media and on Capsicum Seeds

357

Mycoparasitism of Rhizoctonia solani by Endophytic Chaetomium spirale ND35: Ultrastructure and Cytochemistry of the Interaction

358

Mycophenolate mofetil

359

Mycophenolate mofetil - a new treatment for autoimmune hepatitis?

360

Mycophenolate Mofetil (MMF) Efficacy in Glomerulonephritis (GN), a Retrospective Analysis

361

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders

362

Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice

363

Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum

364

Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome

365

Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation

366

Mycophenolate mofetil for Crohnʹs disease?

367

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

368

Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation

369

Mycophenolate mofetil for prevention of acute rejection

370

Mycophenolate mofetil for severe autoimmune haemolytic anemia

371

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

372

Mycophenolate Mofetil for the Treatment of Uveiti Original Reearch Article

373

Mycophenolate mofetil for transplantation: new drug, old problems?

374

Mycophenolate Mofetil for Treatment of Idiopathic Nephrotic Syndrome in Children

375

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome

376

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study

377

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

378

Mycophenolate mofetil in Crohnʹs disease

379

Mycophenolate mofetil in IBD patients

380

Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis

381

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

382

Mycophenolate mofetil monotherapy in liver transplantation

383

Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis

384

Mycophenolate mofetil to rescue children with acute renal transplant rejection

385

Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit

386

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

387

Mycophenolate mofetil versus cyclophosphamide for therapy of lupus nephritis: an evidence-based case report from systematic reviews and metaanalyses

388

Mycophenolate Mofetil versus Cyclosporine in Children with Frequent Relapse Nephrotic Syndrome

389

Mycophenolate mofetil: a new therapeutic option in dermatology

390

Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?

391

Mycophenolate Mofetil; A Review of Indications and Use in a Large Tertiary Hospital

392

Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients

393

Mycophenolate Sodium versus Mycophenolate Mofetil: A Review of Their Comparative Features

394

Mycophenolic acid analogs with a modified metabolic profile Original Research Article

395

Mycophenolic acid as a latent agonist of PPARγ

396

Mycophenolic Acid Concentration on Vietnamese Renal Transplant Recipients

397

Mycophenolic Acid Influences T Helper 2 (Th2) Cytokine Induced Expression of Intercellular Cell Adhesion Molecule-1 (ICAM-1) on Human Endothelial Cells

398

Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages

399

Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145

400

Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation

401

Mycoplasma bovis and otitis in dairy calves in the United Kingdom

402

Mycoplasma bovis Infection with Enzootic Pneumonia Symptoms in a Beef Cattle Farm

403

Mycoplasma bovis-associated disease: Here, there and everywhere

404

Mycoplasma capricolum subsp. capripneumoniae, the cause of contagious caprine pleuropneumonia, comprises two distinct biochemical groups

405

Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders

406

Mycoplasma genitalium and Mycoplasma hominis infection in south Korea during 2018-2020

407

Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome

408

Mycoplasma hominis infections occurring in cardiovascular surgical patients

409

Mycoplasma hominis parasitism of Trichomonas vaginalis

410

Mycoplasma hominis parasitism of Trichomonas vaginalis

411

Mycoplasma hominis parasitism of Trichomonas vaginalis

412

Mycoplasma host specificity: Fact or fiction?

413

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

414

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

415

Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling

416

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

417

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

418

Mycoplasma Infection in Pyospermic Infertile and Healthy Fertile Men

419

Mycoplasma Infection in the Lungs of Cattle: The First Identification of Mycoplasma dispar in Iran

420

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

421

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

422

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia

423

Mycoplasma pneumonia in Cerebrospinal Fluids of Febrile Children With Neurologic Manifestations: A Cross Sectional Study, Tehran, Iran

424

Mycoplasma pneumonia infection and asthma: A clinical study

425

Mycoplasma pneumoniae and Recurrent Respiratory Tract Infection Within One Year After Treatment in Infants: Risk Factors and Prevalence

426

Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia

427

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report

428

Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis

429

Mycoplasma pneumoniae Infection Among Children: A Systematic Review and Meta-analysis of Published Literature

430

Mycoplasma Pneumoniae Infection with Neurologic Complications

431

Mycoplasma pneumoniae pneumonia following assisted ventilation

432

Mycoplasma pneumoniae preceding Lemierre’s syndrome due to Fusobacterium nucleatum complicated by acute Epstein–Barr virus (EBV) infectious mononucleosis in an immunocompetent host

433

Mycoplasma Synoviae and other Associated Bacteria Causing Arthritis in Chicken

434

Mycoplasma wenyonii: A Causative Agent of New Mastitis in Dairy Cows

435

Mycoplasma-like organisms in Hodgkinʹs disease

436

Mycoplasma-pneumoniae-Induced Thrombotic Thrombocytopenic Purpura

437

Mycoplasmas – Identifying hosts for a stealth pathogen

438

Mycoplasmas and oncogenesis

439

Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections

440

Mycoplasmoses of ruminants in France: recent data from the national surveillance network

441

Mycoplasmosis in Slaughtered She-Camels: Pathological Studies

442

Mycoprotein Production from Date Waste Using Fusarium venenatum in a Submerged Culture

443

Myco-remediation of Dairy Wastewater by Naturally Attenuated Aspergillus sp. Responsible for Sulfate Reduction

444

Mycoremediation of Dichlorvos Pesticide Contaminated Soil by Pleurotus pulmonarius (Fries) Quelet

445

Mycorrhiza between Kobresia bellardii (All.) Degel and Terfezia boudieri Chatin

446

Mycorrhiza formation is not needed for early growth induction and growth-related changes in polyamines in Scots pine seedlings in vitro

447

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

448

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

449

Mycorrhizae confer aluminum resistance to tulip-poplar seedlings

450

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

451

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

452

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

453

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

454

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

455

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

456

Mycorrhiza-induced resistance: more than the sum of its parts?

457

Mycorrhiza-induced resistance: more than the sum of its parts?

458

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

459

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

460

MYCORRHIZAL ASSOCIATION IN SOME WEEDS OF curcuma longa FIELDS OF DISTRICT KASUR, PAKISTAN

461

Mycorrhizal association of maritime pine, Pinus pinaster, with Rhizopogon roseolus has contrasting effects on the uptake from soil and root-to-shoot transfer of 137Cs, 85Sr and 95mTc

462

Mycorrhizal colonisation improves fruit yield and water use efficiency in watermelon (Citrullus lanatus Thunb.) grown under well-watered and waterstressed conditions

463

Mycorrhizal colonization and nitrogen uptake by maize: combined effect of tropical earthworms and velvetbean mulch

464

Mycorrhizal colonization of major banana genotypes in six East African environments

465

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

466

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

467

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

468

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

469

Mycorrhizal dependency of Chihuahuan Desert plants is influenced by life history strategy and root morphology

470

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

471

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

472

Mycorrhizal evolution

473

Mycorrhizal fungi biodiversity in Canadian soils

474

Mycorrhizal fungi enhance accumulation and tolerance of chromium in sunflower (Helianthus annuus)

475

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

476

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

477

MYCORRHIZAL FUNGUS (GLOMUS MOSSAE) INOCULATION EFFECTS ON PERFORMANCE AND ROOT BIOMASS DEVELOPMENT OF CACAO SEEDLINGS IN THE NURSERY

478

Mycorrhizal impact on osmotic adjustment in Ocimum basilicum during a lethal drying episode

479

Mycorrhizal networks: des liaisons dangereuses?

480

Mycorrhizal phosphorus enhancement of plants in undisturbed soil differs from phosphorus uptake stimulation by arbuscular mycorrhizae over non-mycorrhizal controls

481

Mycorrhizal protection of chili plants challenged by Phytophthora capsici

482

Mycorrhizal symbiosis and response of sorghum plants to combined drought and salinity stresses

483

Mycorrhizal symbiosis effects on growth of chalk false-brome (Brachypodium pinnatum) are dependent on the environmental light regime

484

Mycorrhizas and tropical soil fertility

485

MYCORRHIZATION AND USE OF SUPERABSORBENT POLYMERS IN TARGETED PRODUCTION OF HARDWOODS PLANTING MATERIAL

486

Mycorrhization of fossil and living plants

487

Mycorrhization of the notabilis and sitiens tomato mutants in relation to abscisic acid and ethylene contents

488

Mycosis fungoides and alopecia areata: A case report

489

Mycosis fungoides and Sézary syndrome

490

Mycosis fungoides during the COVID-19 pandemic: a teledermatology study

491

Mycosis Fungoides of the True Vocal Cord: A Case Report and Review of the Literature

492

Mycosis Fungoides Skin Wound Management With Skin Graft Post Ultraviolet Radiation therapy

493

Mycosis fungoides with an unusual clinicopathological presentation

494

Mycosphaerella graminicola produces a range of cell wall-degrading enzyme activities in vitro that vary with the carbon source

495

Mycosphaerella species associated with leaf disease of Eucalyptus globulus in Ethiopia

496

Mycosphaerella species occurring on Eucalyptus globulus and Eucalyptus nitens plantations of Tasmania, Australia

497

Mycosporine-like amino acid composition of the edible red alga, Palmaria palmata (dulse) harvested from the west and east coasts of Grand Manan Island, New Brunswick

498

Mycosporine-like amino acids (MAAs) protect against UV-B-induced damage in Gyrodinium dorsum Kofoid

499

Mycosporine-like amino acids in the marine dinoflagellate Gyrodinium dorsum: induction by ultraviolet irradiation

500

Mycosporine-like amino acids in the marine red alga Gracilaria cornea - effects of UV and heat

501

Mycosynthesis and characterization of selenium nanoparticles using standard penicillium chrysogenum PTCC 5031 and their antibacterial activity: A novel approach in microbial nanotechnology

502

Mycosynthesis of Silver Nanoparticles by Candida albicans Yeast and its Biological Applications

503

Mycosynthesis: Antibacterial, antioxidant and antiproliferative activities of silver nanoparticles synthesized from Inonotus obliquus (Chaga mushroom) extract

504

Mycotic Aneurysm of External Carotid Artery following Traumatic Brain Injury: Case Report and Review of Literature

505

Mycotic aneurysm of superior mesenteric artery branch presenting as pulsatile abdominal mass

506

Mycotic aneurysm of the aorta: Evolving surgical concept

507

Mycotic Aneurysm of the Descending Thoracic Aorta in a 2-kg Neonate

508

Mycotic Aneurysm of the Left Coronary Artery

509

Mycotic aneurysm of the left main coronary artery producing acute coronary occlusion and purulent pericarditis

510

Mycotic Aneurysm of the Thoracic Aorta Caused by Clostridium septicum

511

Mycotic aneurysm presenting as Pancoastʹs syndrome in an injection drug user

512

Mycotic aneurysm: A diagnostic challenge

513

Mycotic aneurysms of the abdominal aorta

514

Mycotic aneurysms of the thoracic aorta: a diagnostic challenge

515

Mycotic aortic aneurysm as a postsurgical complication: report of a case and review of the literature

516

Mycotic Aortic Aneurysm: Review of the Literature and Report of Two Cases

517

Mycotic Aortocoronary Saphenous Vein Graft Aneurysm Presenting With Unstable Angina Pectoris

518

Mycotic arch aneurysm and aortoesophageal fistula in a patient with melioidosis

519

Mycotic Coronary Artery Aneurysm From Fungal Prosthetic Valve Endocarditis

520

Mycotic false aneurysm of the ascending aorta

521

Mycotic infections in diabetic foot ulcers in Emam Reza hospital, Mashhad, 2006-2008

522

Mycotic infections in diabetic foot ulcers in Emam Reza hospital,Mashhad, 2006-2008

523

Mycotic Keratitis, a State-of-the-Art Review

524

Mycotic pseudoaneursym of the aortic arch: an unusual complication of invasive pulmonary aspergillosis

525

Mycotic pulmonary artery aneurysm diagnosed 18 years after bacterial endocarditis

526

Mycotoxicoses in veterinary medicine: Aspergillosis and penicilliosis

527

Mycotoxicosis in Swine: a Review

528

Mycotoxigenic and Proteolytic Potential of Moulds Associated with Smoked Shark Fish (Chlamydoselachus anguincus)

529

Mycotoxigenic Fusarium species in animal feed

530

Mycotoxin analyses in some home produced eggs in Belgium reveal small contribution to the total daily intake

531

Mycotoxin Contaminating Maize and Grass Silages for Dairy Cattle Feeding: Current State and Challenges

532

Mycotoxin Contamination of Foodstuffs and Feedstuffs in Iran

533

Mycotoxin Contamination of Maize Grains Grown in Karnataka (India)

534

Mycotoxin contamination of the feed supply chain: Implications for animal productivity and feed security

535

Mycotoxin content of organic and conventional oats from southeastern Poland

536

Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies

537

Mycotoxin Genetics and Gene Clusters

538

Mycotoxin glucosylation in commercial wheat varieties: Impact on resistance to Fusarium graminearum under laboratory and field conditions

539

Mycotoxin Management in Agriculture: a Review

540

Mycotoxin management in the European cereal trading sector

541

Mycotoxin occurrence in beer produced in several European countries

542

Mycotoxin occurrence in corn meal and flour traded in São Paulo, Brazil

543

Mycotoxin problem in Africa: Current status, implications to food safety and health and possible management strategies

544

Mycotoxin Production and Molecular Variability of European and American Isolates of Fusarium Culmorum

545

Mycotoxin production by Alternaria alternata strains isolated from red delicious apples in Argentina

546

Mycotoxin production by Alternaria strains isolated from Argentinean wheat

547

Mycotoxin production by Aspergillus, Fusarium and Penicillium species

548

Mycotoxin production by isolates of Fusarium lactis from greenhouse sweet pepper (Capsicum annuum)

549

Mycotoxin production in major crops as influenced by growing, harvesting, storage and processing, with emphasis on the achievement of Food Safety Objectives

550

Mycotoxin production of selected Fusarium species at different culture conditions

551

Mycotoxin protocols: Mary W. Trucksess and Albert E. Pohland (Eds.), Methods in Molecular Biology Inc., Volume 157, John M. Walker, Series Editor, Humana Press, Totowa, New Jersey 07512; 2000; hardback, pp xii+ 244; US$79.50; ISBN 0-089603-623-5; Website:

552

Mycotoxin Regulations for Foods: A Global Update

553

Mycotoxin research and mycoflora in some commercially important agricultural commodities

554

Mycotoxin risk evaluation in feeds contaminated by Aspergillus fumigatus

555

Mycotoxin-degradation profile of Rhodococcus strains

556

Mycotoxin-producing potential of fungi isolated from amaranth seeds in Argentina

557

558

Mycotoxins and food safety.: J.W. DeVries, M.W. Trucksess, L.S. Jackson (Eds.), 2002, Vol. 504, Advances in Experimental Medicine and Biology. Kluwer Academic, New York. 295+xi pp. ISBN 0-306-46780-1. Price?

559

Mycotoxins and food safety: Editors: Jonathan W. Devries, Mary W. Trucksess, and Lauren S. Jackson. Advances in Experimental Medicine and Biology, Vol. 504. Kluwer Academic, New York; xi+295 pp.; hardback, EUR 148.00/USD 135.00/GBP 94.00; ISBN 0-306-46780

560

Mycotoxins and phycotoxins. Advances in determination, toxicology and exposure management

561

Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management, H. Njapeu, S. Trujillo, H. van Egmond, D. Pard (Eds.). Wageningen Academic Publishers (2006), ISBN: 978-90-8686-007-4

562

MYCOTOXINS AND SURFACE AND INTERNAL FUNGI OF MAIZE FROM ETHIOPIA

563

Mycotoxins and the pet food industry: Toxicological evidence and risk assessment

564

Mycotoxins and their effects on human and animal health

565

Mycotoxins Contamination in Tea and Herbal Infusion: A Mini-Review

566

Mycotoxins in a changing global environment – A review

567

Mycotoxins in Agriculture and Food Safety. K. K. Sinha and D. Bhatnagar (eds). 15.5 × 23.4 cm, 520 pp. New York, USA: Marcel Dekker [ http://www.dekker.com], 1998. $175. ISBN 0824701925 (hardback).

568

Mycotoxins in Brazilian corn for animal feed: occurrence and incentives for the private sector to control the level of contamination

569

Mycotoxins in cereals and cereal products in Slovenia – Official control of foods in the years 2008–2012

570

Mycotoxins in edible tree nuts

571

Mycotoxins in food from Jordan: Preliminary survey

572

Mycotoxins in food products available in Qatar

573

Mycotoxins in Food. Detection and Control, N. Magan, M. Olsen (Eds.). Woodhead Publishing Limited, Boca Raton, Boston, New York, Washington, DC, Cambridge (2004), ISBN: 1-85573-7337

574

Mycotoxins in fruits and their processed products: Analysis, occurrence and health implications

575

Mycotoxins in myelopathies of man

576

Mycotoxins in rice

577

Mycotoxins in Silages: Occurrence and Prevention

578

Mycotoxins in two Spanish cheese varieties

579

Mycotoxins occurrence in Argentina’s maize (Zea mays L.), from 1999 to 2010

580

Mycotoxins of Aspergilius fumigatus in pure culture and in native bioaerosols from compost facilities

581

Mycotoxins produced by Fusarium genus in maize: determination by screening and confirmatory methods based on liquid chromatography tandem mass spectrometry

582

Mycotoxins Produced by Fusarium spp. in Isogenic Bt vs. non-Bt Maize Hybrids under European Corn Borer Pressure

583

Mycotoxins: Occurrence, toxicology, and exposure assessment

584

Mycotoxins’ Toxicities - from Consumer Health Safety Concerns, to Mitigation/Treatment Strategies: A Perspective Review

585

Mycotrienins: A new class of potent inhibitors of osteoclastic bone resorption

586

MYCOTROPHIC STRATEGY OF 13 COMMON NEOTROPICAL TREES AND SHRUBS

587

Myctophid feeding ecology and carbon transport along the northern Mid-Atlantic Ridge

588

MyD88 pathway is involved in IL-18-mediated increase in intestine matrix metalloproteinase-9

589

Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round

590

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases

591

Myelin Basic Protein is Down-Regulated in Sheep Affected with Ovine Coenurosis

592

Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis

593

Myelin basic protein–lipid complex: an atomic force microscopy study

594

Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases

595

Myelin breakdown in Alzheimer’s disease: a commentary

596

Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men

597

Myelin characterization of fetal brain with mono-point estimated T1-maps

598

Myelin enhancement of Multiple sclerosis model with gold nanoparticles into the corpus callosum

599

Myelin Formation and Remodeling

600

Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination

601

Myelin glycoproteins targeted by lead in the rodent model of prolonged exposure

602

Myelin growth and coiling

603

Myelin Is a Preferential Target of Aluminum-Mediated Oxidative Damage

604

Myelin Membrane Wrapping of CNS Axons by PI(3,4,5)P3-Dependent Polarized Growth at the Inner Tongue

605

Myelin peptides in multiple sclerosis

606

Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice

607

Myelin Proteolipid Protein-Induced Th1 and Th2 Clones Express TCR with Similar Fine Specificity for Peptide and CDR3 Homology Despite Diverse Vβ Usage

608

Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis

609

Myelin-like protrusions of giant phospholipid vesicles prepared by electroformation

610

Myelin-Liposome Protection against Experimental Autoimmune Encephalomyelitis Is Associated with Reduced Neuroantigen-Specific T-Cell-Mediated Responses

611

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders

612

Myelin-reactive antibodies mediate the pathology of MBP–PLP fusion protein MP4-induced EAE

613

Myelitis due to enterovirus in patient on interferon therapy for chronic hepatitis B: Case report

614

Myeloablative and immunosuppressive properties of treosulfan in mice

615

Myelodysplasia and Mast Cell Leukemia with t(9;22)

616

Myelodysplasia or Myeloneoplasia: Thoughts on the Nosology of Clonal Myeloid Diseases

617

Myelodysplasia with der(1;7)(q10;p10) discovered after an episode of bacterial lymphangitis in a twenty-three-year-old man

618

Myelodysplasia: The good, the fair and the ugly

619

Myelodysplasia: When to treat and how

620

Myelodysplasia-Like Syndrome and End-Stage Liver Disease

621

Myelodysplasic syndromes: A comprehensive review

622

Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura

623

Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13)

624

Myelodysplastic Syndrome after Regression of Transient Abnormal Myelopoiesis in a Down Syndrome Infant: Different Clonal Origin?

625

Myelodysplastic syndrome and a nonrandom chromosomal abnormality t(1;19):: an indolent pathologic entity

626

Myelodysplastic syndrome and aortic valve replacement: additions

627

Myelodysplastic Syndrome Associated with Monosomy 7 in a Child with Bloom Syndrome

628

Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study

629

Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype

630

Myelodysplastic syndrome in an infant: induction of remission by cyclosporin

631

Myelodysplastic Syndrome Manifesting As Sweet’s Syndrome and Brochiolitis Obliterative Organizing Pneumonia

632

Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q

633

Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature

634

Myelodysplastic Syndrome with Atypical Eosinophilia in Association with Ring Chromosome 7: A Case Report

635

Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy

636

Myelodysplastic Syndrome with Clonal Eosinophilia Accompanied by Eosinophilic Pulmonary Interstitial Infiltration

637

Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7): Confirmation of Eosinophil Clonal Involvement by Fluorescence In Situ Hybridization

638

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma

639

Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization)

640

Myelodysplastic syndrome with transformation to AML-M7 in a 46,XX male patient

641

Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring

642

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing

643

Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change

644

Myelodysplastic Syndromes With Nephrotic Syndrome

645

Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease

646

Myelofibrosis in a 24-Year Old Nigerian

647

Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options

648

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

649

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

650

Myelographic Applications in Newborn Healthy and Paraplegic Calves

651

Myeloid Antigen-positive T Cell Acute Lymphocytic Leukemia with t(14;18) and Trisomy 10: Report of a Case and Literature Review

652

Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia

653

Myeloid Cell Leukemia-1 Gene Expression and Clinicopathological Features in Myelodysplastic Syndrome

654

Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model

655

Myeloid cell trafficking and tumor angiogenesis

656

Myeloid differentiation (MyD) primary response genes in hematopoiesis

657

Myeloid differentiation in long term culture of human peripheral blood

658

Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling

659

Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo

660

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs

661

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

662

Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice

663

Myeloid Sarcoma after Allogenic Stem Cell Transplantation forAcute Myeloid Leukemia: Successful Consolidation TreatmentApproaches in Two Patients

664

Myeloid sarcoma of the orbit

665

Myeloid Sarcoma of the peritoneum at older ages: A case report and review of literature

666

Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization

667

Myeloid Sarcoma Presenting as Rectosigmoid Tumour: A Case Report

668

Myeloid Sarcoma Presenting with Lateral Cervical Mass and Eosinophilia; a Diagnostic and Therapeutic Dilemma: Case Report

669

Myeloid Sarcoma: Case Series with Unusual Locations

670

Myeloid/natural killer cell precursor acute leukemia with tetraploidy

671

Myeloid-derived suppressor cell role in tumor-related inflammation

672

Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients

673

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

674

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

675

Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit+CD33−CD38− fraction of umbilical cord CD34+ cells

676

Myelolipomas and other fatty tumours of the adrenals

677

Myeloma aetiology and epidemiology

678

Myeloma appearance after local external beam radiotherapy jet: Is it a new entity?

679

Myeloma Ascites-A Favorable Outcome With Cyclophosphamide Therapy

680

Myeloma bone disease

681

Myeloma cells (5TMM) and their interactions with the marrow microenvironment

682

Myelomatous Pleural Effusion Case report and review of the literature

683

Myelomeningocele: Characterization of a surgically induced sheep model and its central nervous system similarities and differences to the human disease

684

Myelopathy due to hereditary multiple exostoses: CT and MR studies

685

Myelopathy following high voltage electrical injury: a case report

686

Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis

687

Myeloperoxidase −463G > A polymorphism and risk of primary lung cancer in a Korean population

688

Myeloperoxidase activity in chicken heterophils and adherent cells

689

Myeloperoxidase activity in chicken heterophils and adherent cells

690

Myeloperoxidase activity, fibrinogen concentrations and white blood cell counts in healthy and sick foals

691

Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure

692

Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography

693

Myeloperoxidase and Horseradish Peroxidase Catalyze Tyrosine Nitration in Proteins from Nitrite and Hydrogen Peroxide

694

Myeloperoxidase as a Biomarker in Acute Coronary Syndrome: Beware of the Pitfalls

695

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion

696

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis?

697

Myeloperoxidase in Equine Semen: Concentration and Localization during Freezing Processing

698

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia

699

Myeloperoxidase Levels in Patients with PCOS and/or Obesity Before and After Metformin Treatment

700

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease

701

Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome

702

Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol Original Research Article

703

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss

704

Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients

705

Myeloperoxidase-catalyzed formation of PCDD/F from chlorophenols

706

Myeloperoxidase-Catalyzed Oxidation of Tyrosine

707

Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells

708

Myeloperoxidase-catalyzed taurine chlorination: Initial versus equilibrium rate

709

Myeloperoxidase-Dependent Generation of a Tyrosine Peroxide by Neutrophils

710

Myeloperoxidase-Dependent Loss of Malondialdehyde: A Limitation for Detecting Neutrophil-Mediated Lipid Peroxidation

711

Myeloperoxidase-generated oxidants and atherosclerosis

712

Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines

713

Myeloperoxidase-mediated oxidation of high-density lipoproteins: Fingerprints of newly recognized potential proatherogenic lipoproteins

714

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

715

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

716

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

717

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

718

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

719

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

720

Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates

721

Myeloproliferative disorders

722

Myeloproliferative disorders and its associated mutations

723

Myeloproliferative Neoplasm with Prominent Eosinophilia

724

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

725

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

726

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice

727

Myeloprolipherative Disorder Type Chronic Myeloid Leucemia - Eosinophilic Form

728

Myeloprotection following cytotoxic damage: The sooner the better

729

Myeloprotective effect of Triticum aestivum Linn. grass against antineoplastic agents induced bone marrow toxicity in mice

730

Myenteric Denervation of the Gut with Benzalkonium Chloride: A Review of Forty Years of an Experimental Model

731

Myenteric denervation reduces the incidence of gastric tumors in rats

732

Myenteric plexus injury and apoptosis in experimental colitis

733

Myers effect and tachyon condensation Original Research Article

734

Myerson values for games with fuzzy communication structure

735

Myf-5 Revisited: Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice

736

Myhill–Nerode type theory for fuzzy languages and automata

737

738

Myiasis among slaughtered animals in Kashan, Iran: descriptive a veterinary entomological problem in the tropics

739

Myiasis in an 89-year-old man with non-hodgkin lymphoma.

740

Myiasis in Animals and Humans in Northeastern Anatolia

741

Myiasis of Mandible Due to Lucilia sericata, in Diabetic Woman Patient: A Case Report

742

Myiasis With Carcinoma in Situ of the Glans Penis: An Unusual Combination

743

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

744

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

745

Mylar™ and Teflon-AF™ as cell culture substrates for studying endothelial cell adhesion

746

MyLearningMentor: A Mobile App to Support Learners Participating in MOOCs

747

MyLifeBits: holding on to the present to preserve the past

748

Mylonite development in the Hercynian basement of Sardinia (Italy)

749

Mylonitic deformation of gabbro in the lower crust: A case study from the Pankenushi gabbro in the Hidaka metamorphic belt of central Hokkaido, Japan

750

Mylonitization in the lower plate of the Buckskin-Rawhide detachment fault, west-central Arizona: Implications for the geometric evolution of metamorphic core complexes

751

MyMessage: case-based reasoning and multicriteria decision making techniques for intelligent context-aware message filtering

752

Myo- and hepatotoxic effects of cultivated mushrooms in mice

753

MYO/ENDOTHELIAL DIFFERENTIATION OF HUMAN UMBILICAL CORD BLOOD-DERIVED STEM CELLS IN ISCHEMIC LIMB TISSUES

754

Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries

755

Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries

756

Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation

757

Myoblast transplantation for heart failure

758

Myoblast transplants challenged in muscular dystrophy

759

Myoblasts and fibroblasts in stress urinary incontinence

760

Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at risk

761

Myocardial abscess with contained rupture: successful repair

762

Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters

763

Myocardial adaptation to ischaemia – the preconditioning phenomenon

764

Myocardial adenine nucleotides, glycogen, and Na,K-ATPase in patients with idiopathic dilated cardiomyopathy requiring mechanical circulatory support

765

Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload

766

Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep, , ,

767

Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10

768

Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

769

Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia

770

Myocardial and Systemic Iron Depletion in Heart Failure: Implications for Anemia Accompanying Heart Failure

771

Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients

772

Myocardial anti-ischemic effect of BRX-235: Role of nitric oxide and reactive oxygen species

773

Myocardial Apoptosis and Infarction after Ischemia/Reperfusion Are Attenuated by κ-Opioid Receptor Agonist

774

Myocardial apoptosis in heterotopic murine heart transplant model of chronic rejection/graft vasculopathy

775

Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study

776

Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Assist Device–Induced Myocardial Recovery

777

Myocardial atrophy in acquired immunodeficiency syndrome—associated wasting

778

Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X

779

Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months

780

Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy

781

Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition

782

Myocardial blood flow and coronary flow reserve late after anatomical correction of transposition of the great arteries

783

Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy

784

Myocardial blood supply by left ventricle-to-coronary artery channel: An old idea revisited

785

Myocardial blood-flow response during mental stress in patients with coronary artery disease

786

Myocardial bridge over the left anterior descending coronary artery: A case report and review of the literature

787

Myocardial Bridge: Surgical Outcome and Mid-term Follow up

788

Myocardial Bridging

789

Myocardial bridging causing transmural ischemia Successful coronary artery bypass surgery

790

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease

791

Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome

792

Myocardial bridging in adult patients with hypertrophic cardiomyopathy

793

Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis?

794

Myocardial bridging of obtuse marginal branch of the left circumflex artery associated with congenital corrected transposition of the great arteries

795

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy

796

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply

797

Myocardial bridging of the posterolateral branches of the right coronary artery

798

Myocardial bridging of the ramus intermedius coronary artery

799

Myocardial bridging of the right coronary artery and emotional stress: A fatal link?

800

Myocardial bridging on left anterior descending coronary artery evaluated by multidetector computed tomography

801

Myocardial Bridging: Contemporary Understanding of Pathophysiology With Implications for Diagnostic and Therapeutic Strategies

802

Myocardial buffering capacity in ischemia preconditioned rat heads

803

Myocardial Capillaries and Coronary Flow Reserve

804

Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate

805

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis

806

Myocardial cell damage in human hypertension

807

Myocardial Cell Death and Apoptosis in Hibernating Myocardium

808

Myocardial cell lineages in the mammalian embryo: The second heart field

809

Myocardial collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect

810

Myocardial Connexin43 Expression in Left Ventricular Hypertrophy Resulting from Aortic Regurgitation

811

Myocardial contractile dispersion: A new marker for the severity of cirrhosis?

812

Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis

813

Myocardial Contractile Effects of image-Arginine in the Human Allograft

814

Myocardial Contractile Reserve Accurately Predicts Positive Response to Cardiac Resynchronization Therapy

815

Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy

816

Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy

817

Myocardial Contractile Responsiveness to Endothelin-1 in the Post-infarction Rat Model of Heart Failure: Effects of Chronic Quinapril

818

Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography

819

Myocardial contrast echo effect: The dilemm of coronary blood flow and volume

820

Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction

821

Myocardial Contrast Echocardiography Demonstrates That Collateral Flow Can Preserve Myocardial Function Beyond a Chronically Occluded Coronary Artery

822

Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far Review Article

823

Myocardial contrast echocardiography for the detection of coronary artery disease

824

Myocardial Contrast Echocardiography for the Detection of Coronary Artery Stenosis: A Prospective Multicenter Study in Comparison With Single-Photon Emission Computed Tomography Original Research Article

825

Myocardial contrast echocardiography in acute myocardial infarction

826

Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory

827

Myocardial contrast echocardiography in human beings: Correlation of resting perfusion defects to sestamibi single photon emission computed tomography

828

Myocardial Contrast Echocardiography Perfusion Imaging: Still Waiting After All These Years

829

Myocardial contrast echocardiography to assess spontaneous reperfusion during myocardial infarction

830

Myocardial Contrast Echocardiography Versus Dobutamine Echocardiography for Predicting Functional Recovery After Acute Myocardial Infarction Treated With Primary Coronary Angioplasty

831

Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram Original Research Article

832

Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction Original Research Article

833

Myocardial contrast echocardiography with power Doppler imaging

834

Myocardial contrast echocardiography, single-photon emission computed tomography, and regional function analysis for coronary stenosis description during vasodilator stress

835

Myocardial Contrast Echocardiography: An Innovative Technique to Assess Myocardial Perfusion in Hypertensive Patients

836

Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in canine model of coronary thrombosis and reperfusion

837

Myocardial contrast echocardiography: Reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent

838

Myocardial contrast versus dobutamine echocardiography as predictors of late functional recovery in acute myocardial infarction treated with primary PTC

839

Myocardial creatine kinase expression after left ventricular assist device support

840

Myocardial cytochrome c oxidase activity in Swedish moose (Alces alces L.) affected by molybdenosis

841

Myocardial damage after continuous aerobic and anaerobic exercise in rats

842

Myocardial Damage After TAVR Assessed With CMR: A New Piece in a Puzzle?

843

Myocardial damage and left ventricular dysfunction in patients with and without persistent negative t waves after q-wave anterior myocardial infarction

844

Myocardial damage and repair

845

Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure, ,

846

Myocardial damage in multisystem inflammatory syndrome associated with COVID‑19 in children and adolescents

847

Myocardial damage of the entire ventricular region in a patient with acute myocardial infarction

848

Myocardial Deformation and Rotational Profiles in Mitral Valve Prolapse

849

Myocardial deformation and ventricular vortices: physically-based imaging in clinical practice

850

Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction Original Research Article

851

Myocardial Deformation Imaging by Two-Dimensional Speckle-Tracking Echocardiography in Comparison to Late Gadolinium Enhancement Cardiac Magnetic Resonance for Analysis of Myocardial Fibrosis in Severe Aortic Stenosis

852

Myocardial Deformation Indices in Patients with Significant Aortic Regurgitation: A Strain Rate Imaging Study

853

Myocardial deformation recovery from cine MRI using a nearly incompressible biventricular model

854

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas’ Disease: A Marker of Disease Severity Original Research Article

855

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy Original Research Article

856

Myocardial diastolic dysfunction at experimental diabetes mellitus—the role of nitric oxide

857

Myocardial disarray: an architectural disorganization linked with adrenergic stress?

858

Myocardial Distribution of Antegrade Cold Crystalloid and Tepid Blood Cardioplegia

859

Myocardial Doppler velocity imaging—a quantitative technique for interpretation of dobutamine echocardiography

860

Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning

861

Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus

862

Myocardial Dysfunction Caused by Perinatal Asphyxia in Full-term Infants

863

Myocardial Dysfunction in Thalassemia Major: Comparison between Echocardiography and MRI

864

Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of no, TNFα and sphingosine

865

Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model.

866

Myocardial dysfunction: hibernation and remodelling

867

Myocardial dysfunction: hibernation and remodelling

868

Myocardial edema: Comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs

869

Myocardial effects of experimental acute brain death: Evaluation by hemodynamic and biological studies

870

Myocardial Effects of PDE5 Inhibition: More Function With Less Mass

871

Myocardial electrical impedance responds to ischemia and reperfusion in humans

872

Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease

873

Myocardial enterovirus infection with left ventricular dysfunction: benign disease compared with idiopathic dilated cardiomyopathy

874

Myocardial epithelial inclusions in a Holstein calf

875

Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?

876

Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection

877

Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy Original Research Article

878

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat

879

Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure: Contributory Mechanisms

880

Myocardial Extracellular Remodeling Is Associated With Ventricular Diastolic Dysfunction in Children and Young Adults With Congenital Aortic Stenosis

881

Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy

882

Myocardial extramedullary hematopoiesis following myocardial infarction

883

Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitation

884

Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients

885

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with

886

Myocardial Fibrosis Associated with Aldosterone or Angiotensin II Administration: Attenuation by Calcium Channel Blockade

887

Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels

888

Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation

889

Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone

890

Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice

891

Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death

892

Myocardial Flow Reserve in Long-Term Survivors of Repair of Anomalous Left Coronary Artery From Pulmonary Artery

893

Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair

894

Myocardial function and geometry in hypertensive subjects with low levels of afterload

895

Myocardial Function in Egyptian Pediatric Patients With Acute Nephritic Syndrome

896

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5

897

Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone

898

Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors

899

Myocardial Function of Horses Under Sedation with Romifidine Using Two-Dimensional Speckle Tracking

900

Myocardial Function of Hyperthyroid Rats in Presence of Diazepam in Langendorff Setup

901

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging

902

Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders Original Research Article

903

Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease

904

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery Original Research Article

905

Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease Original Research Article

906

Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia

907

Myocardial Glycogen Depletion Cannot Explain the Cardioprotective Effects of Ischemic Preconditioning in the Rat Heart

908

Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload,

909

Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines

910

Myocardial Hydatid Cyst : An Uncommon Complication of Echinococcal Infection

911

Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review

912

Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats

913

Myocardial IL-6 regulation by neurohormones—an in vitro superfusion study

914

Myocardial imaging in patients with defibrillator patch electrodes

915

Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigs

916

Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion

917

Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery

918

Myocardial infarction after an ice-hockey match: Coincidence of myocardial bridging and coronary spasm

919

Myocardial infarction after aspirin cessation in stable coronary artery disease patients

920

Myocardial Infarction after Endoscopic Removal of Foreign Body

921

Myocardial Infarction After Oral Sumatriptan Use in a Woman with Normal Coronary Arteries

922

Myocardial infarction after partial left ventriculectomy

923

Myocardial infarction after partial left ventriculectomy: Reply

924

Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging Original Research Article

925

Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia

926

Myocardial infarction and coronary care units

927

Myocardial infarction and depression: A review article

928

Myocardial infarction and heart failure—a dangerous intersection

929

Myocardial infarction and HELLP: a case of heightened vasomotor reactivity

930

Myocardial Infarction and Hyperglycemia

931

Myocardial infarction and ischemia

932

Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial

933

Myocardial infarction and percent arteriographic stenosis of culprit lesion: Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH) Original Research Article

934

Myocardial Infarction and Regulatory Myosin Light Chain

935

Myocardial infarction and sub-acute ventricular rupture: successful outcome in two cases

936

Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency

937

Myocardial infarction as a complication of new interventional devices

938

Myocardial infarction as complication of left atrial myxoma

939

Myocardial infarction caused by a large coronary artery aneurysm

940

Myocardial infarction caused by a leukemic clot: A case report

941

Myocardial Infarction Caused by Active-Fixation Ventricular Pacing Lead Screwed into the Anterior Descending Coronary Artery

942

Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm

943

Myocardial infarction caused by coronary artery myocardial bridge,

944

Myocardial infarction complicating the initial phase of an ovarian stimulation protocol

945

Myocardial infarction diagnosis by morphology of ventricular extrasystole

946

Myocardial infarction due to lightning strike

947

Myocardial infarction during menses: lessons from trials and errors

948

Myocardial infarction during scuba diving: A case report and review

949

Myocardial Infarction Elevates Inflammation and Contributes to the Formation of Atheroma Plaques in the Aorta of Hypercholesterolaemic Rats

950

Myocardial infarction following a bee sting

951

Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox

952

Myocardial Infarction in a newborn from a diabetic mother

953

Myocardial Infarction in a Patient with Prosthetic Aortic Valve

954

Myocardial infarction in a patient with thrombotic thrombocytopenic purpura

955

Myocardial infarction in a woman with no apparent risk factors

956

Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries

957

Myocardial Infarction in a Young Patient After Acute Exposure to Carbon Monoxide

958

Myocardial infarction in a young woman with antiphospholipid syndrome

959

Myocardial infarction in children

960

Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis

961

Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI

962

Myocardial infarction in mice: Functional characterization and cytokine expression

963

Myocardial Infarction in Newly Diagnosed Hypertensive Medicaid Patients Free of Coronary Heart Disease and Treated with Calcium Channel Blockers

964

Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and Outcomes

965

Myocardial infarction in pregnant women — Case reports

966

Myocardial infarction in pre-war Leeds

967

Myocardial infarction in pre-war Leeds

968

Myocardial infarction in pre-war Leeds

969

Myocardial infarction in sickle-cell disease

970

Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease

971

Myocardial infarction in the C57BL/6J mouse: A quantifiable and highly reproducible experimental model

972

Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)

973

Myocardial infarction in young adults: Angiographic characterization, risk factors, and prognosis (Coronary Artery Surgery Study registry): Zimmerman FH, Cameron A, Fisher LD, et al J Am Coll Cardiol 26:654–661 September 1995

974

Myocardial infarction in young patients

975

Myocardial Infarction Induced by Migraine Therapy

976

Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly

977

Myocardial infarction or inflammation?

978

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

979

Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement

980

Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner

981

Myocardial infarction redefined: Impact on case-load and outcome of patients with suspected acute coronary syndrome and nondiagnostic ECG at presentation

982

Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiolo

983

Myocardial Infarction Resulting From Caffeine Overdose in an Anorectic Woman, ,

984

Myocardial infarction resulting from nonatherosclerotic coronary artery diseases

985

Myocardial infarction risk in relation to zinc concentration in toenails

986

Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures

987

Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome

988

Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI

989

Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography

990

Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy

991

Myocardial infarction with thrombus formation during prolonged intense exercise

992

Myocardial infarction without coronary artery occlusion following mental stress

993

Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance

994

Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today

995

Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?

996

Myocardial infarction: a catabolic disease?

997

Myocardial infarction: a paradigm of success in modern medicine

998

Myocardial infarction: a rare complication of dothiepin overdose

999

Myocardial infarction: changing view of a killer

1000

Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2

بازگشت